NEWS HIGHLIGHTSMedia Articles Related to Flovent (Fluticasone Inhalation)
Asthma Increases Risk for Periodontitis Source: Medscape Allergy & Clinical Immunology Headlines [2017.09.25] People with asthma should pay particularly close attention to their oral health after research found a strong link between the condition and gum disease. WebMD Health News
Could Pests, Dust Lower Kids' Odds for Asthma? Source: MedicineNet Allergy Specialty [2017.09.22] Title: Could Pests, Dust Lower Kids' Odds for Asthma? Category: Health News Created: 9/21/2017 12:00:00 AM Last Editorial Review: 9/22/2017 12:00:00 AM
Asthma Drug Tied to Nightmares, Depression Source: MedicineNet Allergy Specialty [2017.09.22] Title: Asthma Drug Tied to Nightmares, Depression Category: Health News Created: 9/21/2017 12:00:00 AM Last Editorial Review: 9/22/2017 12:00:00 AM
Kids' Colds Linked to Asthma, Lung Problems Later Source: MedicineNet Adenoids and Tonsils Specialty [2017.09.20] Title: Kids' Colds Linked to Asthma, Lung Problems Later Category: Health News Created: 9/19/2017 12:00:00 AM Last Editorial Review: 9/20/2017 12:00:00 AM
Asthma Quiz: Test Your Medical IQ Source: MedicineNet Asthma Complexities Specialty [2017.09.19] Title: Asthma Quiz: Test Your Medical IQ Category: MedicineNet Quiz Created: 6/3/2011 4:21:00 PM Last Editorial Review: 9/19/2017 6:36:12 PM
Published Studies Related to Flovent (Fluticasone Inhalation)
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients
with eosinophilic esophagitis. [2014] esophagitis (EoE) and analyzed esophageal transcriptomes to identify mechanisms... CONCLUSIONS: Daily administration of a high dose of FP induces histologic
Fluticasone impact on airway dendritic cells in smokers: a randomized controlled
trial. [2013] DCs in smokers are unknown... CONCLUSIONS: Resistance to ICS monotherapy in smokers might in part be due to
An integrated analysis of the efficacy of fluticasone furoate nasal spray versus
placebo on the nasal symptoms of perennial allergic rhinitis. [2013] Intranasal corticosteroids are widely prescribed for the treatment of perennial
allergic rhinitis (PAR). The aim of this analysis was to determine whether the
beneficial effects of once-daily (q.d.) fluticasone furoate nasal spray (FFNS)
effectively improved individual nasal symptoms of PAR...
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and
fluticasone propionate) in the treatment of seasonal allergic rhinitis: a
randomized, double-blind, placebo-controlled trial of efficacy and safety. [2012] Many patients with allergic rhinitis (AR) have uncontrolled symptoms despite
available treatment options. This study was designed to evaluate the efficacy and
safety of MP29-02 (a novel intranasal formulation of fluticasone propionate [FP]
and azelastine [AZ] hydrochloride), compared with monotherapy with FP, AZ, and
placebo sprays for the treatment of seasonal allergic rhinitis (SAR)...
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. [2011.10.06] ABSTRACT: BACKGROUND: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and evening), for 8 weeks in patients with persistent asthma... CONCLUSIONS: FF at total daily doses of 200 mcg or 400 mcg was significantly more effective than placebo. FF 400 mcg once daily in the evening had similar efficacy to FF 200 mcg twice daily and all FF regimens had a safety tolerability profile generally similar to placebo. This indicates that inhaled FF is an effective and well tolerated once-daily treatment for mild-to-moderate asthma. TRIAL REGISTRATION: NCT00398645.
Clinical Trials Related to Flovent (Fluticasone Inhalation)
Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth [Recruiting]
Children with mild persistent asthma that have asthma symptoms once or twice a week and use
a daily controller, while children with mild intermittent asthma rarely have asthma symptoms
and do not use a daily controller. Inhaled corticosteroids are the standard treatment for
mild peristent asthma. The purpose of this study is to measure children rate of growth
while on different inhaled corticosteroids.
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma [Completed]
This purpose of this study is to show the superiority and long term safety and efficacy of
adding a long acting beta agonist (salmeterol) to constant dose of an inhaled corticosteroid
(fluticasone propionate) in symptomatic subjects with asthma. The 12-month assessment of
asthma control will provide key information on the efficacy and safety of the combination
therapy. The safety measure will be an assessment of adverse events
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma [Completed]
This purpose of this study is to show the superiority and long term safety and efficacy of
adding a long acting beta agonist (salmeterol) to constant dose of an inhaled corticosteroid
(fluticasone propionate) in symptomatic subjects with asthma. The 12-month assessment of
asthma control will provide key information on the efficacy and safety of the combination
therapy. The safety measure will be an assessment of adverse events
FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects [Completed]
The purpose of this study is to address an Food Drug and Administration (FDA) request to
provide safety data in pre-asthmatic patients, ages 6 months to <12 months, following
administration of fluticasone propionate HFA.
Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENTŪ DISKUSŪ and ADVAIRŪ DISKUSŪ in Patients With Persistent Asthma 12 Years of Age and Older [Active, not recruiting]
Each patient will participate in the study for approximately 7 weeks. Participation will
include a screening period of up to 21 days and 4 treatment periods; each consisting of a
3-day/2-night inpatient period.
Reports of Suspected Flovent (Fluticasone Inhalation) Side Effects
Product Quality Issue (69),
Dyspnoea (64),
Drug Ineffective (50),
Asthma (36),
Cough (33),
Dysphonia (31),
Wheezing (16),
Chest Discomfort (16),
Pneumonia (16),
Oropharyngeal Pain (14), more >>
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 1 ratings/reviews, Flovent has an overall score of 10. The effectiveness score is 10 and the side effect score is 10. The scores are on ten point scale: 10 - best, 1 - worst.
| Flovent review by 31 year old female patient | | Rating |
Overall rating: | | |
Effectiveness: | | Highly Effective |
Side effects: | | No Side Effects | | Treatment Info |
Condition / reason: | | asthma |
Dosage & duration: | | 110 mcg (dosage frequency: twice a day) for the period of daily, since summer 2008 through present |
Other conditions: | | none |
Other drugs taken: | | albuterol, as needed | | Reported Results |
Benefits: | | having suffered from asthma for most of my adult life, I began to rely on the albuterol (which should be only used as a rescue inhaler) multiple time per day. After beginning the Flovent inhaler, my asthma was almost non-existent. |
Side effects: | | It lists that mouth ulcers may occur, but upon following the instructions which say to rinse out the mouth directly after taking the medicine, I have suffered no side effects. |
Comments: | | You only need take two puffs in the morning, and another two puffs before going to bed. That's it! |
|
|